Stay updated on Fruquintinib in Metastatic Colorectal Cancer Clinical Trial
Sign up to get notified when there's something new on the Fruquintinib in Metastatic Colorectal Cancer Clinical Trial page.

Latest updates to the Fruquintinib in Metastatic Colorectal Cancer Clinical Trial page
- Check3 days agoChange DetectedPage revision updated from v3.0.1 to v3.0.2. The 'Back to Top' element was removed.SummaryDifference0.1%
- Check11 days agoChange DetectedThe page has been updated to include a new research article on the efficacy and safety of fruquintinib in patients with refractory metastatic colorectal cancer, along with a revision update from v3.0.0 to v3.0.1.SummaryDifference1%
- Check18 days agoChange DetectedThe webpage has undergone significant updates, including the addition of detailed drug information for Fruquintinib and the inclusion of various facility locations across multiple countries, while also removing previous location listings and some redundant terms.SummaryDifference5%
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.0%
- Check39 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.0%
- Check46 days agoChange DetectedThe web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.SummaryDifference0.4%
Stay in the know with updates to Fruquintinib in Metastatic Colorectal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Fruquintinib in Metastatic Colorectal Cancer Clinical Trial page.